Silo Pharma, Inc.
SILO
$0.6283
-$0.0108-1.69%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
Cost of Revenue | 1.50K | 1.50K | 1.50K | 1.50K | 1.50K |
Gross Profit | 16.60K | 16.60K | 16.60K | 16.60K | 16.60K |
SG&A Expenses | 547.90K | 516.70K | 754.20K | 509.10K | 626.50K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.27M | 1.11M | 1.83M | 1.03M | 1.02M |
Operating Income | -1.25M | -1.09M | -1.81M | -1.01M | -1.00M |
Income Before Tax | -1.20M | -1.03M | -1.73M | -928.80K | -931.80K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -1.20M | -1.03M | -1.73M | -928.80K | -931.80K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -1.20M | -1.03M | -1.73M | -928.80K | -931.80K |
EBIT | -1.25M | -1.09M | -1.81M | -1.01M | -1.00M |
EBITDA | -1.25M | -1.09M | -1.81M | -1.01M | -- |
EPS Basic | -0.19 | -0.23 | -0.39 | -0.22 | -0.31 |
Normalized Basic EPS | -0.12 | -0.14 | -0.24 | -0.13 | -0.19 |
EPS Diluted | -0.19 | -0.23 | -0.39 | -0.22 | -0.31 |
Normalized Diluted EPS | -0.12 | -0.14 | -0.24 | -0.13 | -0.19 |
Average Basic Shares Outstanding | 6.28M | 4.48M | 4.49M | 4.30M | 3.05M |
Average Diluted Shares Outstanding | 6.28M | 4.48M | 4.49M | 4.30M | 3.05M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |